STOCK TITAN

Director Ward buys 89,250 InspireMD (NSPR) shares around $1.15

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

InspireMD, Inc. director Ward Scott R. reported open-market purchases of company common stock. He bought 15,995 shares on May 6 and 73,255 shares on May 7 at a weighted average price of $1.15 per share, with individual trade prices ranging from $1.13 to $1.15. Following these transactions, he directly holds 237,096 shares of InspireMD common stock.

Positive

  • None.

Negative

  • None.
Insider Ward Scott R.
Role null
Bought 89,250 shs ($103K)
Type Security Shares Price Value
Purchase Common Stock 73,255 $1.15 $84K
Purchase Common Stock 15,995 $1.15 $18K
Holdings After Transaction: Common Stock — 237,096 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares bought May 7 73,255 shares Open-market purchase of InspireMD common stock on May 7
Shares bought May 6 15,995 shares Open-market purchase of InspireMD common stock on May 6
Total shares bought 89,250 shares Net buy across two open-market transactions reported
Weighted average price $1.15 per share Average price for reported InspireMD stock purchases
Price range $1.13–$1.15 per share Range of trade prices for the purchased shares
Shares held after 237,096 shares Director’s direct InspireMD holdings following transactions
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
transaction code regulatory
""transaction_code": "P","
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ward Scott R.

(Last)(First)(Middle)
C/O INSPIREMD, INC.
6303 WATERFORD DISTRICT DRIVE, SUITE 215

(Street)
MIAMI FLORIDA 33126

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/06/2026P15,995A$1.15(1)163,841D
Common Stock05/07/2026P73,255A$1.15237,096D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.13 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Remarks:
Exhibit 24.1: Power of Attorney
/s/ Michael Lawless, Attorney-in-Fact for Scott R. Ward05/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did InspireMD (NSPR) director Ward Scott R. report on this Form 4?

Director Ward Scott R. reported buying InspireMD common stock in the open market. He purchased 15,995 shares on May 6 and 73,255 shares on May 7, increasing his direct holdings to 237,096 shares after the reported transactions.

How many InspireMD (NSPR) shares did Ward Scott R. buy and at what price?

He bought a total of 89,250 InspireMD common shares across two days. The weighted average purchase price was $1.15 per share, with individual trades executed within a price range from $1.13 to $1.15, according to the Form 4 footnote.

What are Ward Scott R.’s InspireMD (NSPR) holdings after these Form 4 transactions?

After these open-market purchases, Ward Scott R. directly holds 237,096 shares of InspireMD common stock. This total reflects both reported transactions on May 6 and May 7, as disclosed in the Form 4’s post-transaction ownership figures.

Were the InspireMD (NSPR) shares bought in open-market transactions?

Yes. The filing describes both transactions as open-market purchases of InspireMD common stock. They are coded as “P” on Form 4, which indicates purchases in the open market or similar private transactions at the reported weighted average price.

What price range did InspireMD (NSPR) trades cover in this Form 4?

The footnote states that the reported weighted average prices reflect multiple trades between $1.13 and $1.15 per share. The reporting person notes that detailed breakdowns by exact trade price and size are available upon request from the issuer or regulators.